Physician profile
Raphael Kulawik
NPI 1114238250
$1,556.91
in general payments reported to CMS, 2019-2025
18 companies · $92.60 in 2025
The $92.60 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.29 · 2020: $186 · 2021: $456 · 2022: $151 · 2023: $312 · 2024: $310 · 2025: $92.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $545.12 | 2021-2025 | |
| Abbott Laboratories | $150.00 | 2024 | Mitraclip |
| Lilly USA, LLC | $143.95 | 2020-2021 | |
| Boston Scientific Corporation | $114.67 | 2020 | |
| Pfizer INC. | $106.29 | 2023-2025 | |
| Smith+Nephew, INC. | $102.67 | 2023 | Acticoat 4" X 4", Iodosorb Ointment 40g USA, Collagenase Santyl |
| Currax Pharmaceuticals LLC | $70.08 | 2021-2022 | |
| Watermark Medical, INC. | $56.16 | 2021 | |
| Heartflow, INC. | $49.29 | 2019 | |
| Exact Sciences Corporation | $41.05 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.92 | 2024 | Xifaxan |
| Regeneron Healthcare Solutions, INC. | $34.88 | 2023 | Evkeeza |
| Xeris Pharmaceuticals, INC. | $22.63 | 2022 | |
| Inari Medical, INC. | $20.68 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $19.43 | 2024 | Nuzyra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $17.47 | 2020 | |
| Dexcom, INC. | $14.37 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $13.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Kulawik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.